Insmed
INSM
#933
Rank
โ‚ฌ23.04 B
Marketcap
105,51ย โ‚ฌ
Share price
0.83%
Change (1 day)
-14.14%
Change (1 year)

Earnings for Insmed (INSM)

Earnings in 2026 (TTM): -โ‚ฌ0.94 Billion

According to Insmed's latest financial reports the company's current earnings are โ‚ฌ0.81 Billion. In 2025 the company made an earning of -โ‚ฌ1.05 Billion a decrease over its 2024 earnings that were of -โ‚ฌ0.73 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insmed from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ0.94 Billion-9.82%
2025 -โ‚ฌ1.05 Billion43.91%
2024 -โ‚ฌ0.73 Billion23.71%
2023 -โ‚ฌ0.59 Billion45.77%
2022 -โ‚ฌ0.41 Billion15.83%
2021 -โ‚ฌ0.35 Billion50.19%
2020 -โ‚ฌ0.24 Billion16.4%
2019 -โ‚ฌ0.2 Billion-23.9%
2018 -โ‚ฌ0.27 Billion59.35%
2017 -โ‚ฌ0.17 Billion8.52%
2016 -โ‚ฌ0.16 Billion47.25%
2015 -โ‚ฌ0.11 Billion34.53%
2014 -โ‚ฌ76.01 Million58.83%
2013 -โ‚ฌ47.86 Million35.14%
2012 -โ‚ฌ35.42 Million-31.92%
2011 -โ‚ฌ52.02 Million854.92%
2010 -โ‚ฌ5.45 Million-105.22%
2009 โ‚ฌ0.10 B-905.06%
2008 -โ‚ฌ12.96 Million-27.31%
2007 -โ‚ฌ17.83 Million-62.41%
2006 -โ‚ฌ47.42 Million98.19%
2005 -โ‚ฌ23.93 Million0.03%
2004 -โ‚ฌ23.92 Million159.07%
2003 -โ‚ฌ9.24 Million-69.31%
2002 -โ‚ฌ30.08 Million
2000 -โ‚ฌ27.12 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
โ‚ฌ13.76 B-1,532.77%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
โ‚ฌ9.35 B-1,073.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚ฌ4.41 B-559.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚ฌ21.33 M-102.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚ฌ20.27 Million-97.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
-โ‚ฌ20.51 Million-97.87%๐Ÿ‡บ๐Ÿ‡ธ USA